J. Lieberman

Molecular Biology · 2002–2021

A researcher in the Science corpus: 19 papers; trusts 5 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 278 citations into it; #9,868 of 17,773 by trust here, #1,162 by citations
• Cancer Research — 120 citations into it; #1,462 of 1,780 by trust here, #370 by citations

Whom J. Lieberman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. David P. Bartel
2. Thomas Tuschl
3. Paul Anderson
4. N. Kedersha
5. V. Ambros

Who trusts J. Lieberman overall

1. R. Juliano

Papers from J. Lieberman's perspective

Ordered by how strongly the researchers J. Lieberman trusts endorse each paper. Same corpus, a different order for every researcher.

1. Specificity of microRNA target selection in translational repression. (Genes & Development)
2. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. (Molecules and Cells)
3. Silencing of microRNAs in vivo with ‘antagomirs’ (Nature)
4. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs (Nature reviews genetics)
5. The functions of animal microRNAs (Nature)
6. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. (RNA: A publication of the RNA Society)
7. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. (Cell)
8. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. (New England Journal of Medicine)
9. RNA interference is mediated by 21- and 22-nucleotide RNAs. (Genes & Development)
10. RAS is regulated by the let-7 microRNA family. (Cell)

Their papers

• Inflammasome - activated gasdermin D causes pyroptosis by forming membrane pores (2016) — 2,848 citations
• let-7 regulates self renewal and tumorigenicity of breast cancer cells. (2007) — 1,983 citations
• miR-24 inhibits cell proliferation by suppressing expression of E2F2, MYC and other cell cycle regulatory genes by binding to “seedless” 3′UTR microRNA recognition elements (2009) — 604 citations
• siRNA-directed inhibition of HIV-1 infection (2002) — 743 citations
• Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen (2008) — 1,405 citations
• Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs (2011) — 1,009 citations
• G3BP–Caprin1–USP10 complexes mediate stress granule condensation and associate with 40S subunits (2016) — 603 citations
• RNA interference targeting Fas protects mice from fulminant hepatitis (2003) — 1,135 citations
• Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus (2007) — 667 citations
• Interfering with disease: a progress report on siRNA-based therapeutics (2007) — 1,247 citations
• Desperately seeking microRNA targets (2010) — 528 citations
• Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors (2005) — 1,045 citations
• γ-H2AX Dephosphorylation by Protein Phosphatase 2A Facilitates DNA Double-Strand Break Repair (2005) — 506 citations
• Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown (2015) — 602 citations
• Channelling inflammation: gasdermins in physiology and disease (2021) — 645 citations
• Knocking down disease: a progress report on siRNA therapeutics (2015) — 731 citations
• FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation (2020) — 977 citations
• Gasdermin E suppresses tumor growth by activating anti-tumor immunity (2020) — 1,396 citations
• Death by a thousand cuts: granzyme pathways of programmed cell death. (2008) — 708 citations